Agilent Technologies Inc  

(Public, NYSE:A)   Watch this stock  
Find more results for A
48.56
-0.13 (-0.27%)
Real-time:   11:40AM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 48.17 - 48.63
52 week 34.15 - 49.48
Open 48.37
Vol / Avg. 493,074.00/1.89M
Mkt cap 15.68B
P/E 34.47
Div/yield 0.13/1.09
EPS 1.41
Shares 321.75M
Beta 1.29
Inst. own 89%
Mar 16, 2017
Agilent Technologies Inc Annual Shareholders Meeting (Estimated) - 11:00AM EDT - Add to calendar
Feb 14, 2017
Q1 2017 Agilent Technologies Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 10, 2017
Agilent Technologies Inc at JPMorgan Healthcare Conference
Nov 15, 2016
Q4 2016 Agilent Technologies Inc Earnings Call - Webcast
Nov 15, 2016
Q4 2016 Agilent Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '16) 2016
Net profit margin 11.34% 10.99%
Operating margin 16.47% 14.64%
EBITD margin - 22.75%
Return on average assets 6.51% 6.05%
Return on average equity 11.77% 10.99%
Employees 12,500 -
CDP Score - 89 C

Address

5301 Stevens Creek Blvd
SANTA CLARA, CA 95051-7201
United States - Map
+1-408-3458886 (Phone)
+1-408-3458474 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Officers and directors

Michael R. McMullen President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Didier Hirsch Chief Financial Officer, Senior Vice President
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tang Senior Vice President, General Counsel, Secretary
Bio & Compensation  - Reuters
Dominique P. Grau Senior Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Henrik Ancher-Jensen Senior Vice President, President - Order Fulfillment
Age: 50
Bio & Compensation  - Reuters
Mark Doak Senior Vice President, President - Agilent CrossLab Group
Age: 60
Bio & Compensation  - Reuters
Patrick K. Kaltenbach Senior Vice President, President - Life Sciences and Applied Markets Group
Age: 52
Bio & Compensation  - Reuters
Jacob Thaysen Senior Vice President, President - Diagnostics and Genomics Group
Age: 40
Bio & Compensation  - Reuters
Rodney Gonsalves Principal Accounting Officer, Vice President, Corporate Controller
Age: 50
Bio & Compensation  - Reuters
James G. Cullen Independent Non-Executive Chairman of the Board
Age: 73
Bio & Compensation  - Reuters